• Health & Medicine

No, scientists haven’t “developed a pill that can stop cancer spreading”

Today’s headlines about a ‘pill that could stop cancer spreading’ are premature. But the research is interesting. Today’s headlines about a ‘pill that could stop cancer spreading’ are premature. But the research is interesting.

20 February 2014

• Health & Medicine

Redirecting our immune cells to help fight children's cancer

Immune cells, known as Natural Killer T cells, could be redirected to help fight the childhood cancer, neuroblastoma, according to research. Immune cells, known as Natural Killer T cells, could be redirected to help fight the childhood cancer, neuroblastoma, according to research.

6 November 2013

• Science & Technology
• Health & Medicine

No, doctors did not “inject HIV into a dying girl” to treat her cancer

Experimental cancer treatments often hit the headlines, we've taken a look at the science behind a story involving cancer, HIV and the immune system. Experimental cancer treatments often hit the headlines, we've taken a look at the science behind a story involving cancer, HIV and the immune system.

25 June 2013

• Health & Medicine

Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

Cancer Research UK’s Drug Development Office; Cancer Research Technology, the charity's commercial arm; and biopharmaceutical company, Lorus Therapeutics Inc., have partnered to take a new therapy with the potential to treat solid tumours, into its first clinical trial. Cancer Research UK’s Drug Development Office; Cancer Research Technology, the charity's commercial arm; and biopharmaceutical company, Lorus Therapeutics Inc., have partnered to take a new therapy with the potential to treat solid tumours, into its first clinical trial.

27 November 2012

• Health & Medicine

Three-in-one 'supermolecule' could detect cancer early, help destroy tumours and monitor treatment

The same protein could potentially be targeted to detect precancerous breast cells; deliver radiotherapy to destroy tumours; and monitor the effectiveness of treatment, according to a Cancer Research UK study presented at the NCRI Cancer Conference in Liverpool today. The same protein could potentially be targeted to detect precancerous breast cells; deliver radiotherapy to destroy tumours; and monitor the effectiveness of treatment, according to a Cancer Research UK study presented at the NCRI Cancer Conference in Liverpool today.

6 November 2012

• Science & Technology
• Health & Medicine

The slow dawn of the age of targeted therapies

As NICE approves two new melanoma drugs, we look at how far we’ve come in developing ‘personalised’ cancer care. As NICE approves two new melanoma drugs, we look at how far we’ve come in developing ‘personalised’ cancer care.

2 November 2012

• Health & Medicine

Cancer Research UK receives largest ever donation

Cancer Research UK has been given a gift of Ј10 million from one of its supporters. This is the largest one-off donation the charity has ever received, and comes alongside an additional gift of Ј10 million from the same donor for the University of Southampton. Cancer Research UK has been given a gift of Ј10 million from one of its supporters. This is the largest one-off donation the charity has ever received, and comes alongside an additional gift of Ј10 million from the same donor for the University of Southampton.

18 July 2012

• Health & Medicine
• Science & Technology

ASCO 2012: Is immunotherapy finally coming of age?

6 June 2012

• Health & Medicine

Misleading reporting of the “wonder jab that will kill 90% of cancers”

10 April 2012

• Science & Technology
• Health & Medicine

Podcast: Immunotherapy, plain packaging, a boost for trials, and bacon

24 January 2012

• Science & Technology
• Health & Medicine

NCRI Cancer Conference - day two

8 November 2011

• Health & Medicine

Immunology research is a Nobel cause

5 October 2011